IN167848B - - Google Patents

Info

Publication number
IN167848B
IN167848B IN611/MAS/88A IN611MA1988A IN167848B IN 167848 B IN167848 B IN 167848B IN 611MA1988 A IN611MA1988 A IN 611MA1988A IN 167848 B IN167848 B IN 167848B
Authority
IN
India
Prior art keywords
compositions
psoriasis
formula
treatment
methods
Prior art date
Application number
IN611/MAS/88A
Other languages
English (en)
Inventor
Blank Izhak
Original Assignee
Dexter Biotechnics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexter Biotechnics filed Critical Dexter Biotechnics
Publication of IN167848B publication Critical patent/IN167848B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/49Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IN611/MAS/88A 1987-09-04 1988-08-30 IN167848B (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL83775A IL83775A (en) 1987-09-04 1987-09-04 Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
PCT/US1988/002941 WO1989001930A1 (en) 1987-09-04 1988-09-01 Pharmaceutical compositions for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
IN167848B true IN167848B (hu) 1990-12-29

Family

ID=11058151

Family Applications (1)

Application Number Title Priority Date Filing Date
IN611/MAS/88A IN167848B (hu) 1987-09-04 1988-08-30

Country Status (14)

Country Link
EP (1) EP0328634B1 (hu)
JP (1) JPH0745451B2 (hu)
KR (1) KR890701545A (hu)
AT (1) ATE124681T1 (hu)
AU (1) AU618759B2 (hu)
CA (1) CA1340005C (hu)
DE (1) DE3854121T2 (hu)
DK (1) DK218189A (hu)
FI (1) FI891986A0 (hu)
IL (1) IL83775A (hu)
IN (1) IN167848B (hu)
NO (1) NO891703D0 (hu)
WO (1) WO1989001930A1 (hu)
ZA (1) ZA886097B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
WO1992012952A1 (en) * 1991-01-18 1992-08-06 Dexter Chemical Corporation Malic acid derivatives and compositions for the treatment of psoriasis
US5856418A (en) * 1996-04-16 1999-01-05 Nippon Shokubai Co., Ltd. Water-soluble monomer, water-soluble polymer and their production process and use
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
NZ526100A (en) * 2001-01-12 2005-04-29 Fumapharm Ag Fumaric acid amides
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
AU2004269903B2 (en) 2003-09-09 2010-09-02 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
FI121915B (fi) * 2004-02-06 2011-06-15 Neurofood Ab Oy Koostumus psoriasiksen hoitoon
PL2801354T3 (pl) 2004-10-08 2017-08-31 Forward Pharma A/S Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające ester kwasu fumarowego
EP2137537B8 (en) 2007-02-08 2016-06-01 Biogen MA Inc. Compositions and Uses for Treating Multiple Sclerosis
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
SI2379063T2 (sl) 2009-01-09 2021-09-30 Fwp Ip Aps Farmacevtska formulacija, ki obsega enega ali več estrov fumarne kisline v tableti v erozivnem matriksu
WO2011085211A1 (en) 2010-01-08 2011-07-14 Catabasis Pharmaceuticals, Inc. Fatty acid fumarate derivatives and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790032A (fr) * 1971-10-27 1973-02-01 Elf Union Procede de fonctionnement de bruleurs a emulsion a deux allures
JPS4852741A (hu) * 1971-11-04 1973-07-24
CA982530A (en) * 1972-05-23 1976-01-27 Roger Grenetier Device for storing and packaging materials
DE2703964A1 (de) * 1975-07-08 1978-08-03 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US4362737A (en) * 1981-04-13 1982-12-07 Schaefer Rolf Transdermal carrier materials
DE3444915A1 (de) * 1984-12-08 1986-06-12 Hoechst Ag, 6230 Frankfurt N-maleyl-phenylalaninalkylester, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von n-fumarylphenylalaninalkylestern
JPS6248656A (ja) * 1985-08-28 1987-03-03 Showa Denko Kk N−フマリル−l−フエニルアラニンメチルエステル及びその製法
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates

Also Published As

Publication number Publication date
AU618759B2 (en) 1992-01-09
WO1989001930A1 (en) 1989-03-09
AU2423788A (en) 1989-03-31
FI891986A (fi) 1989-04-26
FI891986A0 (fi) 1989-04-26
NO891703L (no) 1989-04-25
KR890701545A (ko) 1989-12-20
EP0328634B1 (en) 1995-07-05
DE3854121T2 (de) 1996-03-21
NO891703D0 (no) 1989-04-25
EP0328634A4 (en) 1991-08-21
DE3854121D1 (de) 1995-08-10
JPH02501072A (ja) 1990-04-12
ZA886097B (en) 1989-06-28
IL83775A (en) 1991-12-15
DK218189D0 (da) 1989-05-03
IL83775A0 (en) 1988-02-29
CA1340005C (en) 1998-08-18
JPH0745451B2 (ja) 1995-05-17
EP0328634A1 (en) 1989-08-23
ATE124681T1 (de) 1995-07-15
DK218189A (da) 1989-07-03

Similar Documents

Publication Publication Date Title
AU1808488A (en) Compounds for the treatment of alzheimer's disease
HU9301362D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
HK56897A (en) Benzocyclobutyl-or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases
AU3064184A (en) Improved compositions for the treatment of psoriasis
AU563650B2 (en) Pharmaceutical compositions of benzothiophene derivatives
IN167848B (hu)
AU623805B2 (en) New use of anti-progestomimetic compounds
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
EP0303951A3 (en) 2-pyrimidinyl-1-piperazine derivatives for treating alcoholism
GR78106B (hu)
GR3005737T3 (hu)
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
IL89901A0 (en) Strobilurine derivatives
GR3005231T3 (hu)
PH24501A (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones
NO884635L (no) Fremgangsmaate for behandling av voerter.
DE3879709D1 (de) Platin-arzneimittel.
ZA844311B (en) Improved compositions for the treatment of psoriasis
IT9019371A0 (it) Procedimento per il trattamento di foraggi
GB8927771D0 (en) Compositions for treatment of eczema